Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
1(10%)
Results Posted
25%(1 trials)
Terminated
2(20%)

Phase Distribution

Ph not_applicable
8
80%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
N/ANon-phased studies
8(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(4)
Terminated(2)
Other(2)

Detailed Status

Completed4
Terminated2
unknown2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A8 (100.0%)

Trials by Status

terminated220%
not_yet_recruiting110%
unknown220%
recruiting110%
completed440%

Recent Activity

1 active trials
Showing 5 of 10
terminatednot_applicable

Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

NCT06543446
recruitingnot_applicable

Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years

NCT05373940
not_yet_recruitingnot_applicable

Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD)

NCT07415642
terminated

Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy

NCT03590730
unknownnot_applicable

Improving the Criteria for Selecting Patients for Primary Prevention of Sudden Cardiac Death by Arrhythmic Risk Stratification

NCT05539898
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06543446Not Applicable

Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

Terminated
NCT05373940Not Applicable

Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years

Recruiting
NCT07415642Not Applicable

Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD)

Not Yet Recruiting
NCT03590730

Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy

Terminated
NCT05539898Not Applicable

Improving the Criteria for Selecting Patients for Primary Prevention of Sudden Cardiac Death by Arrhythmic Risk Stratification

Unknown
NCT01722942Not Applicable

Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death

Unknown
NCT04014946Not Applicable

Assessment of Risk Factors for Appropriate ICD (Implantable Cardioverter-defibrillator) Intervention in Patients With Ischemic Cardiomyopathy

Completed
NCT02124018

Risk Stratification in Patients With Preserved Ejection Fraction

Completed
NCT00919373Not Applicable

Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy

Completed
NCT00949000Not Applicable

AnalyST Treadmill Study

Completed

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10